10.1007/s10549-017-4358-6 - Reducing chemotherapy use in clinical...

This document has been corrected

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

10.1007/s10549-017-4358-6

Published Online: 2017-06-29

Journal: Breast Cancer Research and Treatment•Publisher: Springer Science and Business Media LLC

Authors: Andrea Stefek•Bahriye Aktas•Benno Nuding•Calvin Chao•Cornelia Liedtke•Doris Augustin•Fatemeh Lorenz-Salehi•Hans H. Kreipe•Marianne Just•Matthias Christgen•Michael Clemens•Nadia Harbeck•Oleg Gluz•Petra Krabisch•Rachel Wuerstlein•Ronald E. Kates•Sherko Kuemmel•Steven Shak•Toralf Reimer•Ulrike Nitz•Wolfram Malter

This document has been corrected

10.1007/s10549-017-4358-6

Published Online: 2017-06-29

Journal: Breast Cancer Research and Treatment

NOW

2019-01-10•Correction

Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial

10.1007/s10549-018-05105-8

* information provided by CrossRef

2019-01-10•Correction

10.1007/s10549-018-05105-8

* information provided by CrossRef

2017-06-29•Published

2019-01-10•Correction

10.1007/s10549-018-05105-8

* information provided by CrossRef

This document has been corrected

10.1007/s10549-017-4358-6

Published Online: 2017-06-29

Journal: Breast Cancer Research and Treatment•Publisher: Springer Science and Business Media LLC